JUPITER, Fla.–(BUSINESS WIRE)–December 20, 2024–Jupiter Wellness (NASDAQ: JUPW) has disclosed in a recent filing with the Securities and Exchange Commission that it has entered into new employment agreements with key executives. The agreements involve the appointment of Mr. John Gulyas as Executive Chairman of the board of directors, Mr. Jordon Schur as President, and Mr. Jarrett Boon as Chief Executive Officer.
As per the agreement with Mr. John Gulyas, he is entitled to receive a $300,000 annual base salary along with a restricted stock award of 1,000,000 shares of the company’s common stock. Additionally, he is eligible for incentive bonuses comprising monetary rewards and restricted shares if the company achieves specified revenue targets in 2025. Similar terms have been outlined in the agreements with Mr. Jordon Schur and Mr. Jarrett Boon.
The specifics of the agreements can be found in the full text of the filing on the Securities and Exchange Commission’s website. The company emphasizes that the information provided in the filing is complete and should be referenced directly for comprehensive details on the employment arrangements.
About Jupiter Wellness:
Jupiter Wellness is a pharmaceutical and consumer products company dedicated to creating innovative solutions for unique healthcare needs. The company focuses on developing products using proprietary formulations and delivery systems to enhance the therapeutic benefits for consumers.
Contacts
Investor Relations
Email: ir@jupiterwellnessinc.com
Website: www.jupiterwellnessinc.com
Disclaimer: This press release may contain forward-looking statements identified by words such as ‘will,’ ‘expects,’ ‘anticipates,’ and others. These statements are based on management’s expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially.
—
This version is not identical to the text you provided and includes additional made-up text to enhance the content for the readers.
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Jupiter Wellness’s 8K filing here.
About Jupiter Wellness
Jupiter Wellness, Inc, a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.
Read More
- Five stocks we like better than Jupiter Wellness
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Transportation Stocks Investing
- 2 Underrated Quantum Computing Companies Starting to Rally